AKASA on October 2, 2026 announced the launch of an autonomous AI platform for the mid-cycle of the healthcare revenue cycle, expanding the South San Francisco company from AI-powered prebill review into autonomous inpatient medical coding and clinical documentation integrity (CDI). AKASA, which describes itself as a leader in generative AI for the healthcare revenue cycle, said its customers represent more than $180 billion in aggregate net patient revenue and roughly 10% of U.S. inpatient…